Exact Mass: 422.1365462
Exact Mass Matches: 422.1365462
Found 500 metabolites which its exact mass value is equals to given mass value 422.1365462
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Losartan
Losartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. Losartan and its longer acting metabolite, E-3174, lower blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); they compete with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Losartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2794 CONFIDENCE standard compound; INTERNAL_ID 8189 CONFIDENCE standard compound; INTERNAL_ID 8607 CONFIDENCE standard compound; INTERNAL_ID 2280 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.
Lamiide
C17H26O12 (422.14241960000004)
Lamiide is a terpene glycoside. Lamiide is a natural product found in Lamium eriocephalum, Lantana viburnoides, and other organisms with data available.
9-Bromo-11beta-hydroxy-16alpha-methylpregn-4-ene-3,20-dione
C22H31BrO3 (422.14564359999997)
Melithiazole E
C20H26N2O4S2 (422.13339160000004)
An organonitrogen heterocyclic antibiotic that is 2,4-bi-1,3-thiazole substituted by an isopropyl group at position 2 and a 3,5,7-trimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl group at position 4 (the 2E,4R,5S,6E stereoisomer). It is isolated from the culture broth of myxobacterium, Cystobacter fuscus, and exhibits antifungal and cytotoxic activity.
Asperlicin E
C25H18N4O3 (422.13788379999994)
A member of the class of asperlicins that is asperlicin C in which the lactam nitrogen of the benzodiazepineone moiety has undergone addition to the 2-position of the 2-3 double bond of the indole moeity, and in which the hydrogen at the 3-position of the indole moiety has been replaced by a hydroxy group. It is a cholecystokinin antagonist.
Rumexoside
Rumexoside is found in herbs and spices. Rumexoside is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock). Rumexoside is found in herbs and spices.
3-(1,1-Dimethylallyl)scopoletin 7-glucoside
3-(1,1-Dimethylallyl)scopoletin 7-glucoside is found in herbs and spices. 3-(1,1-Dimethylallyl)scopoletin 7-glucoside is a constituent of Ruta graveolens (rue). Constituent of Ruta graveolens (rue). 3-(1,1-Dimethylallyl)scopoletin 7-glucoside is found in herbs and spices.
(2-Methyl-3-phenyl-phenyl)methyl (3S)-3-[(Z)-2-chloro-3,3,3-trifluoro-prop-1-enyl]-2,2-dimethyl-cyclopropanecarboxylate
N-Cyclopropyl-1-(3-((1-oxidopyridin-3-yl)ethynyl)phenyl)-1,4-dihydro(1,8)naphthyridin-4-one-3-carboxamide
C25H18N4O3 (422.13788379999994)
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors
Plicatic acid
Riociguat
C - Cardiovascular system > C02 - Antihypertensives > C02K - Other antihypertensives > C02KX - Antihypertensives for pulmonary arterial hypertension C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D020536 - Enzyme Activators
Catechin 7-xyloside
Catechin 7-xyloside is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Catechin 7-xyloside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Catechin 7-xyloside can be found in common hazelnut, which makes catechin 7-xyloside a potential biomarker for the consumption of this food product.
Calealactone B
Lamalbid
C17H26O12 (422.14241960000004)
Lamalbid is a natural product found in Lamium album, Lamium amplexicaule, and other organisms with data available.
2,4,3,4,alpha-Pentahydroxydihydrochalcone 3-C-xyloside
Lepidissipyrone
Enantiomultijugin
Multijugin
Catechin 7-xyloside
Catechin 7-O-beta-D-xyloside
3-O-(2,4-Dimethoxy-6-methylbenzoyl)uridine
C19H22N2O9 (422.13252420000003)
[(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate
C19H22N2O9 (422.13252420000003)
(2R,3S)-7-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5-diol
4-De-O-Ac,4-(2-methylpropanoyl)-Antibiotic FL 120B|FL-120B
C22H18N2O7 (422.11139579999997)
2,3,4,6-Tetra-Ac-alpha-D-(2S)-1-O-Glucopyranosylglycerol
C17H26O12 (422.14241960000004)
3-hydroxybenzyl-4-hydroxybenzoate-4-O-beta-D-glucopyranoside|p-Hydroxybenzoyl calleryanin
8alpha-(4-hydroxymethacryloyloxy)-hirsutinolide-13-O-acetate
1alpha-(4-hydroxymethacryloyloxy)-2beta-acetoxy-3alpha,4alpha-epoxy-8alpha-hydroxyeudesm-11(13)-en-6alpha,12-olide
(2R*,4R*,5R*,6S*,8S*,10R*)-1-oxo-2-hydroxy-4,5-epoxy-8-methacryloxy-13-acetoxygermacr-7(11)-en-6,12-olide
alpha,alpha-dihydro-3,3-dihydroxy-5beta-D-O-glucopyranosyloxy-4-methoxystilbene|alpha,beta-dihydrorhaponticin
8alpha-epoxymethacryloyloxy-hirsutinolide-13-O-acetate
6beta-Hydroxyvernopappolid-8-O-methacrylat|8-(2-Methylpropenoyl),13-Ac-6,8,9,13-Tetrahydroxy-1-oxo-4,7(11)-germacradien-12,6-olide
kwansonine A|N2-(1-beta-D-fructopyranosyl)-N5-(2,5-dihydro-2-furyl-3-hydroxymethyl)-gamma-hydroxyglutamine
4-(3,4-dihydroxybenzoyloxymethyl)phenyl-beta-D-glucopyranoside|4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O-beta-D-glucopyranoside|4-(O-beta-D-glycopyranosyl)benzyl protocatechoate|amburoside A|amburoside D|OV-16
3(S)-hydroxy-2,2-dimethyl-dihydropyranocoumarin-8-beta-D-glucopyranosyl|corsicarin
3,5,6-trihydroxy-4-methoxybenzophenone-2-O-alpha-L-rhamnopyranoside|elegaphenonoside
4alpha,5beta-epoxy-4-hydroxypectoralide-14-O-acetate
1-Desoxy-8-(2,3-epoxyisobutyryloxy)-10alpha-hydroxyhirsutinolid|8-(2,3-Epoxy-2-mehylpropanoyl)-13-Ac-1,4-Epoxy-8,10,13-trihydroxy-5,7(11)-germacradien-12,6-olide
(1S)-1,5-anhydro-1-[2,4-dihydroxy-3-(3-hydroxybenzoyl)-6-methoxyphenyl]-D-glucitol|2,6,3-trihydroxy-4-methoxybenzophenone 3-beta-D-glucosylpyranoside|rhodanthenone C
2,3-dihydroxy-4-methoxybenzophenone-6-O-beta-glucopyranoside
11,13-dehydrolactuside C|9alpha-hydroxy-11,13-dehydroleucodin-9-O-beta-glucopyranoside
(E)-dimethyl 4-(3-(4-hydroxy-3-methoxyphenyl)acryloyloxy)-7-oxooxepane-2,4-dicarboxylate|paederoxepane A
3,4,5,6-tetrahydroxy-2-O-alpha-L-arabinosylbenzophenone
1-(4-hydroxy-3-methoxyphenyl)-6-(p-hydroxybenzoyl)-beta-D-glucopyranose|dunnianoside D
1-(4-hydroxy-2-methoxyphenyl)-6-(p-hydroxybenzoyl)-beta-D-glucopyranose|dunnianoside E
2alpha3beta4alpha-trihydroxy-4beta-(acetoxymethyl)-8alpha(4-methacrylate)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide
(rel-3R,3aS,9aR)-3,3a,9,9a-tetrahydro-6-hydroxy-3a,8-dimethoxy-3,7,9a-trimethyl-1-oxo-5-(1-oxobutyl)-1H-furo-[3,4-b]-1-benzopyran-3-carboxylic acid|pallenic acid
2alpha-hydroxycyclohex-4-en-1beta-yl 2-O-[(Z)-p-coumaroyl]-beta-D-glucopyranoside
15-deschloro-3beta-acetoxy-15-hydroxychlorojanerin
3,5,4,5-tetrahydroxy-7-methoxy-6-[1-(p-hydroxy-phenyl)ethyl]flavanone
6-Methoxy-2-acetyl-3-methyl-1,4-naphthoquinone-8-O-??-D-glucopyranoside
6-[(2-hydroxylbenzoyloxy)methyl]-2-hydroxyphenol-1-O-beta-D-glucopyranoside|idesin salicylate
1beta,10alpha-epoxy-4-hydroxypectoralide-14-O-acetate
4-(beta-D-glucopyranosyloxy)-phenyl 4-hydroxy-3-methoxybenzoate|jiamizioside D
8-((6-ethyl-4-hydroxy-5-methyl-2-oxo-2H-pyran-3-yl)methyl)-5,7-dihydroxy-2-phenylchroman-4-one
6-((6-ethyl-4-hydroxy-5-methyl-2-oxo-2H-pyran-3-yl)methyl)-5,7-dihydroxy-2-phenylchroman-4-one
(2R,3S)-7-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5-diol
2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-3,4,5-triol
(2R,3S)-7-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5-diol
C17H26O12_Cyclopenta[c]pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,6,7-trihydroxy-7-methyl-, methyl ester, (1S,4aS,5S,6S,7R,7aS)
C17H26O12 (422.14241960000004)
C19H22N2O9_Uridine, 3-(2,4-dimethoxy-6-methylbenzoate)
C19H22N2O9 (422.13252420000003)
C17H26O12_Cyclopenta[c]pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,6-dihydroxy-7-(hydroxymethyl)-, methyl ester, (1S,4aS,6R,7S,7aS)
C17H26O12 (422.14241960000004)
C21H26O9_(1aS,3R,4R,5S,5aS,8aR,10R,10aS)-4-Acetoxy-3-hydroxy-3,10-dimethyl-6-methylene-2,7-dioxododecahydrooxireno[7,8]cyclodeca[1,2-b]furan-5-yl methacrylate
losartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.
C19H22N2O9_Uridine, 2-(2,4-dimethoxy-6-methylbenzoate)
C19H22N2O9 (422.13252420000003)
(1R,3R,4S,6S,8R,9R,10S,11S)-9-(acetyloxy)-8-hydroxy-3,8-dimethyl-12-methylidene-7,13-dioxo-5,14-dioxatricyclo[9.3.0.0⁴,⁶]tetradecan-10-yl 2-methylprop-2-enoate
(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate
C19H22N2O9 (422.13252420000003)
methyl (1S,4aS,6R,7S,7aS)-5,6-dihydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)
2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-3,4,5-triol
(2R,3S)-7-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5-diol [IIN-based: Match]
8-Aminomethylphenylpyridoindole-guanine
C23H18N8O1 (422.16034979999995)
(1R,3R,4S,6S,8R,9R,10S,11S)-9-(acetyloxy)-8-hydroxy-3,8-dimethyl-12-methylidene-7,13-dioxo-5,14-dioxatricyclo[9.3.0.0⁴,⁶]tetradecan-10-yl 2-methylprop-2-enoate_major
[(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate_major
C19H22N2O9 (422.13252420000003)
Ala Cys Asp Asp
Ala Cys Glu Thr
C15H26N4O8S (422.14712760000003)
Ala Cys Thr Glu
C15H26N4O8S (422.14712760000003)
Ala Asp Cys Asp
Ala Asp Asp Cys
Loxoprofen Metabolite (b-D-Glucopyranuronic acid, 1-[a-methyl-4-[(2-oxocyclopentyl)methyl]benzeneace
Ala Asp Met Ser
C15H26N4O8S (422.14712760000003)
Ala Asp Ser Met
C15H26N4O8S (422.14712760000003)
Ala Glu Cys Thr
C15H26N4O8S (422.14712760000003)
Ala Glu Thr Cys
C15H26N4O8S (422.14712760000003)
Ala Met Asp Ser
C15H26N4O8S (422.14712760000003)
Ala Met Ser Asp
C15H26N4O8S (422.14712760000003)
Ala Ser Asp Met
C15H26N4O8S (422.14712760000003)
Ala Ser Met Asp
C15H26N4O8S (422.14712760000003)
Ala Thr Cys Glu
C15H26N4O8S (422.14712760000003)
Ala Thr Glu Cys
C15H26N4O8S (422.14712760000003)
Cys Ala Asp Asp
Cys Ala Glu Thr
C15H26N4O8S (422.14712760000003)
Cys Ala Thr Glu
C15H26N4O8S (422.14712760000003)
Cys Cys Pro Thr
Cys Cys Thr Pro
Cys Asp Ala Asp
Cys Asp Asp Ala
Cys Asp Glu Gly
Cys Asp Gly Glu
Cys Asp Ser Val
C15H26N4O8S (422.14712760000003)
Cys Asp Val Ser
C15H26N4O8S (422.14712760000003)
Cys Glu Ala Thr
C15H26N4O8S (422.14712760000003)
Cys Glu Asp Gly
Cys Glu Gly Asp
Cys Glu Thr Ala
C15H26N4O8S (422.14712760000003)
Cys Phe Gly Pro
C19H26N4O5S (422.16238260000006)
Cys Phe Pro Gly
C19H26N4O5S (422.16238260000006)
Cys Gly Asp Glu
Cys Gly Glu Asp
Cys Gly Phe Pro
C19H26N4O5S (422.16238260000006)
Cys Gly Pro Phe
C19H26N4O5S (422.16238260000006)
Cys Pro Cys Thr
Cys Pro Phe Gly
C19H26N4O5S (422.16238260000006)
Cys Pro Gly Phe
C19H26N4O5S (422.16238260000006)
Cys Pro Thr Cys
Cys Ser Asp Val
C15H26N4O8S (422.14712760000003)
Cys Ser Val Asp
C15H26N4O8S (422.14712760000003)
Cys Thr Ala Glu
C15H26N4O8S (422.14712760000003)
Cys Thr Cys Pro
Cys Thr Glu Ala
C15H26N4O8S (422.14712760000003)
Cys Thr Pro Cys
Cys Val Asp Ser
C15H26N4O8S (422.14712760000003)
Cys Val Ser Asp
C15H26N4O8S (422.14712760000003)
Asp Ala Cys Asp
Asp Ala Asp Cys
Asp Ala Met Ser
C15H26N4O8S (422.14712760000003)
Asp Ala Ser Met
C15H26N4O8S (422.14712760000003)
Asp Cys Ala Asp
Asp Cys Asp Ala
Asp Cys Glu Gly
Asp Cys Gly Glu
Asp Cys Ser Val
C15H26N4O8S (422.14712760000003)
Asp Cys Val Ser
C15H26N4O8S (422.14712760000003)
Asp Asp Ala Cys
Asp Asp Cys Ala
Asp Asp Ser Ser
C14H22N4O11 (422.12850219999996)
Asp Glu Cys Gly
Asp Glu Gly Cys
Asp Gly Cys Glu
Asp Gly Glu Cys
Asp Gly Met Thr
C15H26N4O8S (422.14712760000003)
Asp Gly Thr Met
C15H26N4O8S (422.14712760000003)
Asp Met Ala Ser
C15H26N4O8S (422.14712760000003)
Asp Met Gly Thr
C15H26N4O8S (422.14712760000003)
Asp Met Ser Ala
C15H26N4O8S (422.14712760000003)
Asp Met Thr Gly
C15H26N4O8S (422.14712760000003)
Asp Ser Ala Met
C15H26N4O8S (422.14712760000003)
Asp Ser Cys Val
C15H26N4O8S (422.14712760000003)
Asp Ser Asp Ser
C14H22N4O11 (422.12850219999996)
Asp Ser Met Ala
C15H26N4O8S (422.14712760000003)
Asp Ser Ser Asp
C14H22N4O11 (422.12850219999996)
Asp Ser Val Cys
C15H26N4O8S (422.14712760000003)
Asp Thr Gly Met
C15H26N4O8S (422.14712760000003)
Asp Thr Met Gly
C15H26N4O8S (422.14712760000003)
Asp Val Cys Ser
C15H26N4O8S (422.14712760000003)
Asp Val Ser Cys
C15H26N4O8S (422.14712760000003)
Glu Ala Cys Thr
C15H26N4O8S (422.14712760000003)
Glu Ala Thr Cys
C15H26N4O8S (422.14712760000003)
Glu Cys Ala Thr
C15H26N4O8S (422.14712760000003)
Glu Cys Asp Gly
Glu Cys Gly Asp
Glu Cys Thr Ala
C15H26N4O8S (422.14712760000003)
Glu Asp Cys Gly
Glu Asp Gly Cys
Glu Gly Cys Asp
Glu Gly Asp Cys
Glu Gly Met Ser
C15H26N4O8S (422.14712760000003)
Glu Gly Ser Met
C15H26N4O8S (422.14712760000003)
Glu Met Gly Ser
C15H26N4O8S (422.14712760000003)
Glu Met Ser Gly
C15H26N4O8S (422.14712760000003)
Glu Ser Gly Met
C15H26N4O8S (422.14712760000003)
Glu Ser Met Gly
C15H26N4O8S (422.14712760000003)
Glu Thr Ala Cys
C15H26N4O8S (422.14712760000003)
Glu Thr Cys Ala
C15H26N4O8S (422.14712760000003)
Phe Cys Gly Pro
C19H26N4O5S (422.16238260000006)
Phe Cys Pro Gly
C19H26N4O5S (422.16238260000006)
Phe Gly Cys Pro
C19H26N4O5S (422.16238260000006)
Phe Gly Pro Cys
C19H26N4O5S (422.16238260000006)
Phe Pro Cys Gly
C19H26N4O5S (422.16238260000006)
Phe Pro Gly Cys
C19H26N4O5S (422.16238260000006)
Gly Cys Asp Glu
Gly Cys Glu Asp
Gly Cys Phe Pro
C19H26N4O5S (422.16238260000006)
Gly Cys Pro Phe
C19H26N4O5S (422.16238260000006)
Gly Asp Cys Glu
Gly Asp Glu Cys
Gly Asp Met Thr
C15H26N4O8S (422.14712760000003)
Gly Asp Thr Met
C15H26N4O8S (422.14712760000003)
Gly Glu Cys Asp
Gly Glu Asp Cys
Gly Glu Met Ser
C15H26N4O8S (422.14712760000003)
Gly Glu Ser Met
C15H26N4O8S (422.14712760000003)
Gly Phe Cys Pro
C19H26N4O5S (422.16238260000006)
Gly Phe Pro Cys
C19H26N4O5S (422.16238260000006)
Gly Met Asp Thr
C15H26N4O8S (422.14712760000003)
Gly Met Glu Ser
C15H26N4O8S (422.14712760000003)
Gly Met Ser Glu
C15H26N4O8S (422.14712760000003)
Gly Met Thr Asp
C15H26N4O8S (422.14712760000003)
Gly Pro Cys Phe
C19H26N4O5S (422.16238260000006)
Gly Pro Phe Cys
C19H26N4O5S (422.16238260000006)
Gly Ser Glu Met
C15H26N4O8S (422.14712760000003)
Gly Ser Met Glu
C15H26N4O8S (422.14712760000003)
Gly Thr Asp Met
C15H26N4O8S (422.14712760000003)
Gly Thr Met Asp
C15H26N4O8S (422.14712760000003)
Met Ala Asp Ser
C15H26N4O8S (422.14712760000003)
Met Ala Ser Asp
C15H26N4O8S (422.14712760000003)
Met Asp Ala Ser
C15H26N4O8S (422.14712760000003)
Met Asp Gly Thr
C15H26N4O8S (422.14712760000003)
Met Asp Ser Ala
C15H26N4O8S (422.14712760000003)
Met Asp Thr Gly
C15H26N4O8S (422.14712760000003)
Met Glu Gly Ser
C15H26N4O8S (422.14712760000003)
Met Glu Ser Gly
C15H26N4O8S (422.14712760000003)
Met Gly Asp Thr
C15H26N4O8S (422.14712760000003)
Met Gly Glu Ser
C15H26N4O8S (422.14712760000003)
Met Gly Ser Glu
C15H26N4O8S (422.14712760000003)
Met Gly Thr Asp
C15H26N4O8S (422.14712760000003)
Met Ser Ala Asp
C15H26N4O8S (422.14712760000003)
Met Ser Asp Ala
C15H26N4O8S (422.14712760000003)
Met Ser Glu Gly
C15H26N4O8S (422.14712760000003)
Met Ser Gly Glu
C15H26N4O8S (422.14712760000003)
Met Thr Asp Gly
C15H26N4O8S (422.14712760000003)
Met Thr Gly Asp
C15H26N4O8S (422.14712760000003)
Pro Cys Cys Thr
Pro Cys Phe Gly
C19H26N4O5S (422.16238260000006)
Pro Cys Gly Phe
C19H26N4O5S (422.16238260000006)
Pro Cys Thr Cys
Pro Phe Cys Gly
C19H26N4O5S (422.16238260000006)
Pro Phe Gly Cys
C19H26N4O5S (422.16238260000006)
Pro Gly Cys Phe
C19H26N4O5S (422.16238260000006)
Pro Gly Phe Cys
C19H26N4O5S (422.16238260000006)
Pro Thr Cys Cys
Ser Ala Asp Met
C15H26N4O8S (422.14712760000003)
Ser Ala Met Asp
C15H26N4O8S (422.14712760000003)
Ser Cys Asp Val
C15H26N4O8S (422.14712760000003)
Ser Cys Val Asp
C15H26N4O8S (422.14712760000003)
Ser Asp Ala Met
C15H26N4O8S (422.14712760000003)
Ser Asp Cys Val
C15H26N4O8S (422.14712760000003)
Ser Asp Asp Ser
C14H22N4O11 (422.12850219999996)
Ser Asp Met Ala
C15H26N4O8S (422.14712760000003)
Ser Asp Ser Asp
C14H22N4O11 (422.12850219999996)
Ser Asp Val Cys
C15H26N4O8S (422.14712760000003)
Ser Glu Gly Met
C15H26N4O8S (422.14712760000003)
Ser Glu Met Gly
C15H26N4O8S (422.14712760000003)
Ser Gly Glu Met
C15H26N4O8S (422.14712760000003)
Ser Gly Met Glu
C15H26N4O8S (422.14712760000003)
Ser Met Ala Asp
C15H26N4O8S (422.14712760000003)
Ser Met Asp Ala
C15H26N4O8S (422.14712760000003)
Ser Met Glu Gly
C15H26N4O8S (422.14712760000003)
Ser Met Gly Glu
C15H26N4O8S (422.14712760000003)
Ser Ser Asp Asp
C14H22N4O11 (422.12850219999996)
Ser Val Cys Asp
C15H26N4O8S (422.14712760000003)
Ser Val Asp Cys
C15H26N4O8S (422.14712760000003)
Thr Ala Cys Glu
C15H26N4O8S (422.14712760000003)
Thr Ala Glu Cys
C15H26N4O8S (422.14712760000003)
Thr Cys Ala Glu
C15H26N4O8S (422.14712760000003)
Thr Cys Cys Pro
Thr Cys Glu Ala
C15H26N4O8S (422.14712760000003)
Thr Cys Pro Cys
Thr Asp Gly Met
C15H26N4O8S (422.14712760000003)
Thr Asp Met Gly
C15H26N4O8S (422.14712760000003)
Thr Glu Ala Cys
C15H26N4O8S (422.14712760000003)
Thr Glu Cys Ala
C15H26N4O8S (422.14712760000003)
Thr Gly Asp Met
C15H26N4O8S (422.14712760000003)
Thr Gly Met Asp
C15H26N4O8S (422.14712760000003)
Thr Met Asp Gly
C15H26N4O8S (422.14712760000003)
Thr Met Gly Asp
C15H26N4O8S (422.14712760000003)
Thr Pro Cys Cys
Val Cys Asp Ser
C15H26N4O8S (422.14712760000003)
Val Cys Ser Asp
C15H26N4O8S (422.14712760000003)
Val Asp Cys Ser
C15H26N4O8S (422.14712760000003)
Val Asp Ser Cys
C15H26N4O8S (422.14712760000003)
Val Ser Cys Asp
C15H26N4O8S (422.14712760000003)
Val Ser Asp Cys
C15H26N4O8S (422.14712760000003)
SC-51089
C22H19ClN4O3 (422.11456140000007)
3-(1,1-Dimethylallyl)scopoletin 7-glucoside
Rumexoside
4-methyl-N-[(1R,2R)-2-[(4-methylphenyl)sulfonylamino]cyclohexyl]benzenesulfonamide
C20H26N2O4S2 (422.13339160000004)
N-[2-[[2-chloro-4-(methylsulphonyl)phenyl]azo]-5-(diethylamino)phenyl]acetamide
C19H23ClN4O3S (422.11793180000006)
(1s,2s)-(-)-n,n-di-p-tosyl-1,2-cyclohexanediamine
C20H26N2O4S2 (422.13339160000004)
2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-[(4-bromophenyl)methyl]-1-oxo-, 1,1-dimethylethyl est
C20H27BrN2O3 (422.12049320000006)
[2-butyl-5-chloro-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
benzene-1,3-dicarboxylic acid,dimethyl benzene-1,4-dicarboxylate,ethane-1,2-diol
benzene-1,3-dicarboxylic acid,butane-1,4-diol,terephthalic acid
3-[5-(3-METHYL-5-ISOXAZOLYL)-2-(METHYLSULFONYL)-4-PYRIMIDINYL]-1-PIPERIDINECARBOXYLIC ACID,1,1-DIMETHYLETHYL ESTER
C19H26N4O5S (422.16238260000006)
olodaterol hydrochloride
C21H27ClN2O5 (422.16084020000005)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Olodaterol (BI1744) hydrochloride is a selective, long acting β2-adrenoceptor (β2-AR) agonist (EC50=0.1 nM and pKi= 9.14 for human β2-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis[1][2][3].
1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D065147 - Viral Fusion Protein Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D065147 - Viral Fusion Protein Inhibitors > D023581 - HIV Fusion Inhibitors
Mavatrep
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
3-(2-Aminoquinazolin-6-Yl)-4-Methyl-N-[3-(Trifluoromethyl)phenyl]benzamide
2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide
C22H16F2N4O3 (422.1190409999999)
Izonsteride
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent
Amburoside A
A beta-D-glucoside in which a beta-D-glucopyranosyl residue is attached at position 4 of 4-hydroxybenzyl 3,4-dihydroxybenzoate via a glycosidic linkage. It is isolated from the trunk barks of Amburana cearensis and exhibits antimalarial, neuroprotective, hepatoprotective and antioxidant activities.
(S)-S-Benzyl 6-amino-2-(((benzyloxy)carbonyl)amino)hexanethioate hydrochloride
C21H27ClN2O3S (422.1430822000001)
Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(dimethylamino)-, chloride
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes
9-(3-(3,5-Dinitrobenzoylamino)propyl)-1,2,3,4-tetrahydrocarbazole
{4-[3-(6,7-Diethoxy-quinazolin-4-ylamino)-phenyl]-thiazol-2-yl}-methanol
C22H22N4O3S (422.14125420000005)
2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine
Riociguat
C - Cardiovascular system > C02 - Antihypertensives > C02K - Other antihypertensives > C02KX - Antihypertensives for pulmonary arterial hypertension C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D020536 - Enzyme Activators
(12aR,17bS,18aS)-17b-hydroxy-13,17b,18,18a-tetrahydro-11H-indolo[3,2:4,5]pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine-5,11(12aH)-dione
C25H18N4O3 (422.13788379999994)
2-amino-4-[3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-methyl-9-oxo-5H-imidazo[1,2-a]purin-7-yl]butanoic acid
6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-3-(2-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C22H22N4O3S (422.14125420000005)
6-[(3-Methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-ylidenemethyl)-amino]-1,2-dihydro-6-aza-cyclopenta[cd]phenalene-5,7-dione
C25H18N4O3 (422.13788379999994)
methyl 5-chloro-3-[[2-(4-ethoxycarbonylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
2-{2-[2-(Acetyloxy)-5-methoxy-3-nitrophenyl]vinyl}-4-quinolinyl acetate
C22H18N2O7 (422.11139579999997)
N-(1,3-benzodioxol-5-yl)-2-[4-(4-phenyl-2-thiazolyl)-1-piperazinyl]acetamide
C22H22N4O3S (422.14125420000005)
3-(4-Methylphenyl)sulfonyl-1-(3-oxolanylmethyl)-2-pyrrolo[3,2-b]quinoxalinamine
C22H22N4O3S (422.14125420000005)
3,5-dimethoxy-N-[1-[oxo(thiophen-2-yl)methyl]-3,4-dihydro-2H-quinolin-6-yl]benzamide
C23H22N2O4S (422.13002120000004)
3-[[1-(dimethylsulfamoyl)-4-piperidinyl]oxy]-N-[(3-methyl-5-isoxazolyl)methyl]benzamide
C19H26N4O5S (422.16238260000006)
4-ethoxy-N-[(Z)-(2-phenyl-2,3-dihydrochromen-4-ylidene)amino]benzenesulfonamide
C23H22N2O4S (422.13002120000004)
2-acetamido-2-deoxy-alpha-L-galactopyranuronosyl-(1->3)-N-acetyl-D-quinovosamine
A disaccharide formed by an alpha1->3 glycosidic linkage between N-acetyl-L-galactosaminuronic acid and N-acetylquinovosamine.
3-cyclohexyl-6-[4-(2,3-dichlorophenyl)-1-piperazinyl]-1H-pyrimidine-2,4-dione
C20H24Cl2N4O2 (422.12762239999995)
N-(3-methylphenyl)-2-[4-[(E)-2-(5-nitro-2,4-dioxo-1H-pyrimidin-6-yl)ethenyl]phenoxy]acetamide
3,4,5-Trihydroxy-6-[8-hydroxy-6-(3-methylbut-2-enyl)-2-oxochromen-7-yl]oxyoxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[2-(7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl)propan-2-yloxy]oxane-2-carboxylic acid
5-[6-hydroxy-2-phenyl-4-[(E)-2-phenylethenyl]-2,3-dihydro-1-benzouran-3-yl]benzene-1,3-diol
3,4,5-trihydroxy-6-[6-[(E)-3-hydroxy-3-methylbut-1-enyl]-2-oxochromen-7-yl]oxyoxane-2-carboxylic acid
CID 5702111
C20H26N2O6S (422.15114960000005)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
[3-hydroxy-5-methyl-4-[(2R,3S)-2,3,4-trihydroxybutoxy]carbonylphenyl] 2,4-dihydroxy-6-methylbenzoate
6,7,8,15,16,17-Hexahydro-7,16-methanocyclodeca[1,2-b:6,7-b]dinaphthalene-1,4,9,14,19-pentone
(3as,9as,9bs)-6,9-dimethyl-3-methylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(3ar,4s,6ar,8s,9r,9as,9bs)-8-(acetyloxy)-9-hydroxy-9-(hydroxymethyl)-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
methyl (1s,4as,6s,8r,8as)-6-hydroxy-8-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,8h,8ah-pyrano[3,4-c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)
methyl (2e,6e)-7-[2-(2-isopropyl-1,3-thiazol-4-yl)-1,3-thiazol-4-yl]-3,5-dimethoxy-4-methylhepta-2,6-dienoate
C20H26N2O4S2 (422.13339160000004)
methyl (2s)-2-[(1s,2s)-1-{[(1s,4ar,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate
C17H26O12 (422.14241960000004)
methyl (1s,4as,5r,6r,7s,7as)-5,6-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)
4-(2,4-dihydroxy-6-methylbenzoyloxy)-2,3-dihydroxybutyl 2,4-dihydroxy-6-methylbenzoate
(1r,3r,4s,6s,8s,9r,10s,11s)-9-(acetyloxy)-8-hydroxy-3,8-dimethyl-12-methylidene-7,13-dioxo-5,14-dioxatricyclo[9.3.0.0⁴,⁶]tetradecan-10-yl (2e)-but-2-enoate
methyl 4a,5,7-trihydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)
[(1s,2s,4r,6s,7e,10s)-6,10-bis(acetyloxy)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradeca-7,11-dien-12-yl]methyl acetate
(1s,2s,4r,7r,9r,11s)-13-[(acetyloxy)methyl]-4,9-dimethyl-14-oxo-3,8,15-trioxatetracyclo[10.3.0.0²,⁴.0⁷,⁹]pentadec-12-en-11-yl (2s)-2-methyloxirane-2-carboxylate
methyl (1r,4ar,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)
2-{[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}oxane-3,4,5-triol
(1r,10r,11s)-6-[(acetyloxy)methyl]-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
(22s)-17,18,22-trimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-1(14),3,5,9,11,15(20),16,18-octaen-13-one
6-oxocyclohex-2-ene-1-carbonyl 2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate
2-[3-hydroxy-2-(4-hydroxybenzoyl)-5-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r)-4-(2,4-dihydroxy-6-methylbenzoyloxy)-2,3-dihydroxybutyl 2,4-dihydroxy-6-methylbenzoate
(1r)-6-oxocyclohex-2-ene-1-carbonyl 2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate
2-{[(4r,5r,6e,8e,11s)-3,5-dihydroxy-4-methyl-14,16-dioxo-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12-pentaen-11-yl]amino}benzoic acid
11,12-dihydroxy-3,10-dimethyl-3-(3-methyl-5-oxo-2h-furan-2-yl)-7-oxo-6,13-dioxatetracyclo[7.5.0.0¹,⁵.0²,¹²]tetradecan-8-yl acetate
(1r,2r,4s,6s,8s,10r)-12-[(acetyloxy)methyl]-6-hydroxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
methyl (2r)-2-[(2,2-dimethylchromen-6-yl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
(3ar,4s,6ar,8s,9r,9as,9bs)-9-[(acetyloxy)methyl]-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
4-[(acetyloxy)methyl]-9-(hydroxymethyl)-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2-(hydroxymethyl)prop-2-enoate
12-[(acetyloxy)methyl]-9-hydroxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
(2r,3s)-5-{[(2s,3r,4s)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
methyl (1s,4ar,6r,7r,7as)-4a,6,7-trihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
C17H26O12 (422.14241960000004)